Cyclic AMP signaling inhibits megakaryocytic differentiation by targeting transcription factor 3 (E2A) cyclin-dependent kinase inhibitor 1A (CDKN1A) transcriptional axis.
about
Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.The gene expression signature of anagrelide provides an insight into its mechanism of action and uncovers new regulators of megakaryopoiesis.Hematopoietic transcription factors and differential cofactor binding regulate PRKACB isoform expression.Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
P2860
Cyclic AMP signaling inhibits megakaryocytic differentiation by targeting transcription factor 3 (E2A) cyclin-dependent kinase inhibitor 1A (CDKN1A) transcriptional axis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@ast
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@en
type
label
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@ast
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@en
prefLabel
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@ast
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@en
P2093
P2860
P356
P1476
Cyclic AMP signaling inhibits ...... (CDKN1A) transcriptional axis.
@en
P2093
Adam N Goldfarb
Jeremy D Rubinstein
Kamaleldin E Elagib
P2860
P304
19207-19215
P356
10.1074/JBC.M112.366476
P407
P577
2012-04-17T00:00:00Z